JIMMIE KEENE: Open Payments
NPI 1972260552 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 68 payments from 10 companies in 2025. Trend: 2023 $682 · 2024 $1,253 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 47 | $257 |
| CVRx, Inc. | 2 | $114 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Novo Nordisk Inc | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: LifeVest, Barostim Neo System, LEQVIO, Wegovy, ELIQUIS, CAMZYOS, FARXIGA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
